National surveillance of dialysis-associated diseases in the United States, 2001.
about
Effect of daily hemodialysis on monocytes apoptosis.Mechanical integrity of hemodialysis catheters after exposure to a novel catheter lock solutionA review of evolving dialysis catheter technologies.Infections in hemodialysis: a concise review. Part II: blood transmitted viral infectionsMeta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease.Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis.Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation.Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease.New hepatitis B vaccine formulated with an improved adjuvant system.Response rates to HB vaccine in CKD stages 3-4 and hemodialysis patientsHepatitis B and C in dialysis units in Kosova.Seropositivity for anti-HCV core antigen is independently associated with increased all-cause, cardiovascular, and liver disease-related mortality in hemodialysis patients.Standardized prevalence ratios for chronic hepatitis C virus infection among adult Japanese hemodialysis patients.Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on Dialysis.Dialyzer reuse and mortality risk in patients with end-stage renal disease: a systematic review.Immunization in end-stage renal disease: opportunity to improve outcomes.Viral hepatitis infections among dialysis patients: Thailand registry report.Alteplase vs. urokinase for occluded hemodialysis catheter: A randomized trial.Occluded Tunneled Venous Catheter in Hemodialysis Patients: Risk Factors and Efficacy of Alteplase.Diagnostic Performance of an Immunoassay for Simultaneous Detection of Hcv Core Antigen and Antibodies among Haemodialysis Patients.Effective use of alteplase for occluded tunneled venous catheter in hemodialysis patients.De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.Surveillance of infection control procedures in dialysis units in Japan: a preliminary study.The effect of hepatic insufficiency on the safety and pharmacokinetics of paricalcitol (Zemplar).
P2860
Q33210504-A647CAE9-53C6-47B9-94DE-BFFA84277B49Q33696391-2268FCD3-315C-404E-B004-7B6A431E122AQ34563639-C8EE3FFC-EC4A-460B-A98F-FA69AB95C5D1Q35532440-EB4AB983-C25A-4D7F-A9B1-12A6297E0801Q35966083-1F1D8458-E701-4EEA-B641-846C09BF1AE1Q35987881-04366F53-28AE-48B6-B92C-BA9F49EB1D9CQ36072570-3BDF470E-5B5C-485A-9E8F-310DEF09413FQ36555974-7E902262-5B09-4875-885A-4888FC0769A8Q36780117-1784A5F3-D95F-4D0C-A52F-ADEDF93DD7F5Q36789845-9AA92A0E-E2CE-4BDC-B650-854CFCF59679Q37223538-3554B816-A84F-4752-9695-731ABA460734Q37506465-81ECC8CA-34FF-46DC-A6AB-8C64C0647C40Q37510993-C4CC3E40-9F8F-4019-A89A-6CAB200552A1Q37692546-5BF82D13-4EEB-4CDD-AE38-AA734B6C965FQ37986995-23E280A1-B1B1-4F0D-8C3F-6CBCD8AA2E13Q38113298-BED665C3-4DA8-414E-A3B1-5B45194D0CEAQ39519637-E52CC722-EDA4-426B-98EB-2878E6751EEAQ40802065-7F39C36C-0A74-4391-9695-923DC1763834Q41306852-5F8161A8-B3A7-4949-9370-279910038E0AQ42235935-C14FC1FD-F847-4249-9C9A-A3A67DF974A9Q42244691-834884F8-3F9B-431B-BE2D-A52E4586D602Q46414212-B806A827-D3C9-4383-B37A-7541A75F71FDQ51242307-72830526-3040-4D80-B1FF-C0D006D821D3Q53602111-11A80CDF-EA57-41A4-B875-A5F7FE23E93B
P2860
National surveillance of dialysis-associated diseases in the United States, 2001.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
National surveillance of dialysis-associated diseases in the United States, 2001.
@en
National surveillance of dialysis-associated diseases in the United States, 2001.
@nl
type
label
National surveillance of dialysis-associated diseases in the United States, 2001.
@en
National surveillance of dialysis-associated diseases in the United States, 2001.
@nl
prefLabel
National surveillance of dialysis-associated diseases in the United States, 2001.
@en
National surveillance of dialysis-associated diseases in the United States, 2001.
@nl
P2093
P1433
P1476
National surveillance of dialysis-associated diseases in the United States, 2001.
@en
P2093
Jerome I Tokars
Matthew J Arduino
Miriam J Alter
P304
P356
10.1111/J.0894-0959.2004.17339.X
P50
P577
2004-07-01T00:00:00Z